Immediate Impact
66 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Works of Xiaolin Liu being referenced
Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: A randomized controlled study
2018
Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xiaolin Liu | 45 | 85 | 128 | 103 | 26 | 317 | |
| Zhining Liu | 36 | 57 | 157 | 88 | 26 | 355 | |
| Xiaojuan Du | 19 | 97 | 165 | 107 | 15 | 298 | |
| Qinghui Niu | 22 | 82 | 195 | 152 | 25 | 333 | |
| Shengsen Chen | 48 | 74 | 168 | 95 | 22 | 288 | |
| Hu Zhang | 50 | 68 | 176 | 115 | 26 | 335 | |
| Lin Guan | 44 | 67 | 103 | 68 | 24 | 284 | |
| Ling Zhang | 23 | 74 | 177 | 68 | 28 | 347 | |
| Shengjia Chen | 27 | 70 | 141 | 60 | 20 | 327 | |
| Wen Meng | 33 | 97 | 151 | 93 | 17 | 369 | |
| Xin Chen | 19 | 95 | 147 | 37 | 21 | 336 |
All Works
Login with ORCID to disown or claim papers
Loading papers...